Home/Filings/4/A/0000947871-14-000188
4/A//SEC Filing

CASTLIGHT HEALTH, INC. 4/A

Accession 0000947871-14-000188

CIK 0001433714operating

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 7:29 PM ET

Size

22.6 KB

Accession

0000947871-14-000188

Insider Transaction Report

Form 4/AAmended
Period: 2014-03-19
Transactions
  • Conversion

    Series D Preferred Stock

    2014-03-19345,0640 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (345,064 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2014-03-191,037,7880 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (1,037,788 underlying)
  • Conversion

    Series B Preferred Stock

    2014-03-192,590,0900 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (2,590,090 underlying)
  • Conversion

    Series C Preferred Stock

    2014-03-193,162,1630 total(indirect: By LLC)
    Exercise: $0.00Class A Common Stock (3,162,163 underlying)
  • Conversion

    Class A Common Stock

    2014-03-19+7,655,3507,733,386 total(indirect: See footnote)
    Exercise: $0.00Class B Common Stock (7,655,350 underlying)
  • Conversion

    Series A Preferred Stock

    2014-03-19520,2450 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (520,245 underlying)
Transactions
  • Conversion

    Series B Preferred Stock

    2014-03-192,590,0900 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (2,590,090 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2014-03-191,037,7880 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (1,037,788 underlying)
  • Conversion

    Series A Preferred Stock

    2014-03-19520,2450 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (520,245 underlying)
  • Conversion

    Series D Preferred Stock

    2014-03-19345,0640 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (345,064 underlying)
  • Conversion

    Series C Preferred Stock

    2014-03-193,162,1630 total(indirect: By LLC)
    Exercise: $0.00Class A Common Stock (3,162,163 underlying)
  • Conversion

    Class A Common Stock

    2014-03-19+7,655,3507,733,386 total(indirect: See footnote)
    Exercise: $0.00Class B Common Stock (7,655,350 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2014-03-19520,2450 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (520,245 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2014-03-191,037,7880 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (1,037,788 underlying)
  • Conversion

    Series B Preferred Stock

    2014-03-192,590,0900 total(indirect: See footnote)
    Exercise: $0.00Class A Common Stock (2,590,090 underlying)
  • Conversion

    Series C Preferred Stock

    2014-03-193,162,1630 total(indirect: By LLC)
    Exercise: $0.00Class A Common Stock (3,162,163 underlying)
  • Conversion

    Series D Preferred Stock

    2014-03-19345,0640 total(indirect: Maverick Fund II, Ltd.)
    Exercise: $0.00Class A Common Stock (345,064 underlying)
  • Conversion

    Class A Common Stock

    2014-03-19+7,655,3507,733,386 total(indirect: See footnote)
    Exercise: $0.00Class B Common Stock (7,655,350 underlying)
Footnotes (5)
  • [F1]In connection with the consummation of Castlight Health Inc.'s initial public offering, each share of convertible preferred stock automatically converted into one (1) share of Class A common stock for no additional consideration. All shares of Class A common stock issued upon conversion were aggregated for purposes of this Report.
  • [F2]Each share of Class A common stock is convertible at any time at the option of the holder, into one share of Class B common stock at any time after Castlight Health Inc.'s initial public offering.
  • [F3]Maverick Capital, Ltd. ("Maverick Capital") is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as the investment manager for each of the portfolio funds that directly hold the reported securities. Maverick Capital Management, LLC ("Maverick") is the general partner of Maverick Capital. Lee S. Ainslie III is the manager of Maverick who is granted sole investment decision pursuant to Maverick's limited liability company regulations. Each reporting owner disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  • [F4]Maverick USA Private Investments, LLC held 833,333 shares of Series A-1 preferred stock; and Maverick Fund II, Ltd. held 204,455 shares of Series A-1 preferred stock.
  • [F5]Maverick Fund Private Investments, Ltd. held 2,252,252 shares of Series B preferred stock; and Maverick USA Private Investments, LLC held 337,838 shares of Series B preferred stock.

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeoperating

Related Parties

1
  • filerCIK 0001433714

Filing Metadata

Form type
4/A
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 7:29 PM ET
Size
22.6 KB